VirtualScopics Backlog Exceeds a Record $... ( 115% increase ...)

VirtualScopics Backlog Exceeds a Record $20 Million

Date:7/15/2008

115% increase over prior year

ROCHESTER, N.Y., July 15 /PRNewswire-FirstCall/ -- VirtualScopics, Inc. (Nasdaq: VSCP), a leading provider of quantitative imaging for clinical trials, today announced that its backlog currently exceeds $20 million compared to $9.3 million at the same time a year ago, a greater than 100% increase. The company calculates backlog as the amount remaining to be recognized from active contracts and awards. Included in the backlog is approximately $11 million in 2008 project awards, and expansions to current studies, which compares to approximately $5.7 million for the same period in 2007.

"We are extremely pleased that our project backlog has exceeded $20 million for the first time in our history, this is a tremendous achievement for the company," said VirtualScopics' President and Chief Executive Officer, Jeff Markin. "Our growth in backlog coupled with a greater than 90% year over year increase in new contract awards are the best indicators of the acceptance and demand in the marketplace for our services." He further added, "We are excited about the progress to date and are looking forward to continued momentum as we enter the second half of the year."

About VirtualScopics, Inc.

VirtualScopics, Inc. is a leading provider of imaging solutions to accelerate drug and medical device development. VirtualScopics has developed a robust software platform for analysis and modeling of both structural and functional medical images. In combination with VirtualScopics' industry-leading experience and expertise in advanced imaging biomarker measurement, this platform provides a uniquely clear window into the biological activity of drugs and devices in clinical trial patients, all
'/>"/>

SOURCE VirtualScopics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related medicine news :

1. VirtualScopics Announces $4.35 Million Private Placement
2. Kendle Delivers Record Sales and Backlog and Strong Growth in Operating Margin for Third Quarter 2007
3. MDwise Enrollment Exceeds 300,000 Members
4. Milliman Says 2008 Medical Cost for American Family of Four Exceeds $15,600
5. Liberator Medical Holdings Exceeds December Sales
6. Liberator Medical Supply Exceeds Projected November Sales
7. Accuray Exceeds 4,000 Lung Cancer Patients Treated with CyberKnife(R) System
8. The Menninger Clinic Unveils Plans for Mental Health Epicenter; Exceeds Halfway Point in $125 Million Capital Campaign
9. AdvaMed 2007 Exceeds Attendance Expectations With More Than 1,100 Participants from 35 States and 25 Countries
10. Electronic Medical Records Are No Longer Limited to Physicians with Deep Pockets
11. Chair, Ranking Member of U.S. House Judiciary Committee Urge DOJ to do Careful Study of Environmental Record of Vedanta/Sterlite, Other Would-Be Buyers of ASARCO

Post Your Comments:

(Date:5/24/2013)... May 23 (HealthDay News) -- Certain statins -- ... your chances of developing type 2 diabetes, a ... for patients taking atorvastatin (brand name Lipitor), rosuvastatin ... Focusing on almost 500,000 Ontario residents, researchers ... developing diabetes were low in patients prescribed statins. ...

(Date:5/24/2013)... National Geographic questioned in an article on ... remembrance is getting lost in the swirl of summer kickoff. ... prompted some research and analysis on the subject based on ... statistical evaluation of around 180 ecards shared by Americans, suggests ... emotions of fun and celebration. In the modern era ...

(Date:5/24/2013)... Dallas, Texas (PRWEB) May 24, 2013 ... to 2022” provides an overview of the risk factors ... markets (8MM) (US, France, Germany, Italy, Spain, UK, Australia, ... incident cases of meningococcal disease segmented by age (<1, ... serogroup (B, C, Y, and W-135) in these markets. ...

(Date:5/24/2013)... 2013 Just about any bodyweight training program ... a trainer based in Dallas, GA that uses a variety ... pushup that is not used enough. , “The medicine ... standard pushup more challenging. By keeping your hands on a ... abs are being worked much harder than a standard pushup. ...

(Date:5/24/2013)... (PRWEB) May 24, 2013 Patients who ... more likely to suffer from gastroesophageal reflux disease or ... reported in a study published today. , The article, ... Proximal Exposure as Measured by Hypopharyngeal Multichannel Intraluminal Impedance” ... could be of great importance to individuals who live ...

Breaking Medicine News(10 mins):Health News:Could Statins Raise Diabetes Risk? 2 Health News:Could Statins Raise Diabetes Risk? 3 Health News:Is Memorial Day More Than A Three-Day Weekend 2 Health News:Meningococcal Disease Market Analysis and 2022 Forecasts in New Research Report at RnRMarketResearch.com 2 Health News:Meningococcal Disease Market Analysis and 2022 Forecasts in New Research Report at RnRMarketResearch.com 3 Health News:Meningococcal Disease Market Analysis and 2022 Forecasts in New Research Report at RnRMarketResearch.com 4 Health News:Medicine Ball Pushups, a Unique Bodyweight Chest Exercise, Released in Video from BodyweightTorch.com 2 Health News:West Penn Allegheny Health System Physicians Pinpoint Gastroesophageal Reflux Disease (GERD) as a Factor That May Cause Chronic Cough 2

[0] Could Statins Raise Diabetes Risk?[0] Is Memorial Day More Than A Three-Day Weekend [0] Meningococcal Disease Market Analysis and 2022 Forecasts in New Research Report at RnRMarketResearch.com [0] Medicine Ball Pushups, a Unique Bodyweight Chest Exercise, Released in Video from BodyweightTorch.com [0] West Penn Allegheny Health System Physicians Pinpoint Gastroesophageal Reflux Disease (GERD) as a Factor That May Cause Chronic Cough

... million, up 7.6% from the first ... quarter of 2007., - Same ... March 31, 2008 over the corresponding period ended in 2007.,- Cash From Facility ... 19% increase over the first period of 2007, and was $0.41 per ...

... drugs that work by blocking brain molecules similar to ... in young children, according to a new study from ... is known to be an appetite stimulant, and a ... Acomplia) developed by Sanofi-Aventis and awaiting approval for use ...

... The American Academy,of Physician Assistants (AAPA), representing ... U.S., is pleased to join other national,organizations ... Treating Tobacco Use and Dependence: 2008 Update., ... even stronger,evidence to support the efforts of ...

... SAO PAULO, Brazil, May 7 Medial Saude S/A,(BOVESPA: MEDI3) (MEDIAL SAUDE) announces the following webcast:, ... When: Thursday, May 8, 2008 @ 12:00 PM EDT, Where: ... Internet -- Simply log on to the web at the ... Conference call dial-in phone numbers: ...

... a Puzzling Pediatric Tumor--, PHILADELPHIA, May 7 ... for the,first time identified a chromosome region that is ... an often fatal childhood cancer., The investigators found ... of chromosome 6 raises the risk that a child ...

... French . , Ottawa (May 7, 2008) ... today funding from the Canadian Institutes of Health Research ... over $298 million. Minister Clement was joined by Dr. ... Po-Yin Cheung, a neonatologist and CIHR-funded researcher from the ...

Brookdale Announces First Quarter 2008 Results MIT study suggests caution on new anti-obesity drug in kids AAPA Endorses 2008 Public Health Service Guidelines for Treating Tobacco Use and Dependence Webcast Alert: Medial Saude S/A Announces First Quarter 2008 Earnings Conference Call Webcast Researchers Find Gene Location That Gives Rise to Neuroblastoma, an Aggressive Childhood Cancer CIHR news: health research touching lives

(Date:5/23/2013)... 2013 Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA ... 2013 Life Science Firm of the Year by the Tech ... honored at the TCM,s 25 th Annual Tech Awards ... Tech Awards Celebration recognizes the leaders and innovators in the ... and the surrounding regions. "We are ...

(Date:5/23/2013)... 23, 2013 Amgen (NASDAQ: AMGN ) ... Healthcare Conference on Thursday, May 30, 2013, at the Westin ... 9:20 a.m. Eastern Daylight Time. Arvind Sood ... at the conference. Live audio of the presentation can be ... , under Investors. A replay of the webcast will also ...

(Date:5/23/2013)... -- Hearing health affects a man,s lifestyle, and if he ... professionally engaged, he should address any hearing loss he may ... Better Hearing Institute (BHI) is delivering to men around ... , which leads up to and includes Father,s Day. This ... June 16. To help men address their ...

Breaking Medicine Technology:Vanda Pharmaceuticals Named the 2013 Life Science Firm of the Year by the Tech Council of Maryland 2 Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises 2 Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises 3 Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises 4

[0] Vanda Pharmaceuticals Named the 2013 Life Science Firm of the Year by the Tech Council of Maryland [0] Amgen to Present at the Deutsche Bank 38th Annual Healthcare Conference [0] Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises

... & MENLO PARK, Calif.--(BUSINESS WIRE)--Jun,4, 2007 - ... the presentation of data from its Quinamed(R),(amonafide ... a genotypically optimised dose of Quinamed in,heavily ... tumors. The,key outcomes from this study were ...

... in Journal Heart Finds Taxus Stent,Implantation of Multiple Stents ... for Another Procedure, , MIAMI LAKES, Fla., ... analysis of data from the Western Denmark Heart,Registry found ... open a clogged artery were less,likely to need another ...

Cached Medicine Technology:ChemGenex Reports Successful Personalized Dosing of Quinamed at,ASCO 2 ChemGenex Reports Successful Personalized Dosing of Quinamed at,ASCO 3 ChemGenex Reports Successful Personalized Dosing of Quinamed at,ASCO 4 New Study Suggests Better Patient Outcomes with CYPHER,Sirolimus-Eluting Coronary Stent than with Taxus Stent in,Real-World Clinical Settings 2 New Study Suggests Better Patient Outcomes with CYPHER,Sirolimus-Eluting Coronary Stent than with Taxus Stent in,Real-World Clinical Settings 3

ChemGenex Reports Successful Personalized Dosing of Quinamed at,ASCO New Study Suggests Better Patient Outcomes with CYPHER,Sirolimus-Eluting Coronary Stent than with Taxus Stent in,Real-World Clinical Settings

... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...

... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...

... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...

Medicine Products:

T-Cell Immunodeficiency Extended Profile T-Cell Clonality Assessment by Restriction Fragment Southern Blot Hybridization, Fluid Syphilis Antibody, IgM by ELISA Susceptibility